Overview
3C syndrome, also known as Ritscher-Schinzel syndrome or craniocerebellocardiac syndrome, is a rare congenital disorder characterized by the combination of cranial, cerebellar, and cardiac malformations — hence the name '3C.' The condition affects multiple body systems, most prominently the brain, heart, and craniofacial structures. Key craniofacial features include macrocephaly, prominent forehead, hypertelorism (widely spaced eyes), depressed nasal bridge, and downslanting palpebral fissures. Cerebellar abnormalities typically involve Dandy-Walker malformation or other posterior fossa defects, which can contribute to developmental delay and intellectual disability of variable severity. Congenital heart defects are common and may include septal defects, hypoplastic left heart, and other structural cardiac anomalies. The syndrome was first described by Ritscher and Schinzel in 1987. Both autosomal recessive and autosomal dominant forms have been identified. Autosomal recessive forms (Ritscher-Schinzel syndrome 1) are caused by mutations in the KIAA0196 gene (also known as WASHC5), while an autosomal dominant form (Ritscher-Schinzel syndrome 2) has been linked to mutations in the CCDC22 gene, and a third form involves the WASHC5 gene as well. Additional features may include ocular anomalies, cleft palate, skeletal abnormalities, and growth retardation. The severity of the condition varies considerably among affected individuals. There is no cure for 3C syndrome, and management is supportive and symptom-based. Treatment typically involves surgical correction of congenital heart defects when indicated, neurosurgical intervention for hydrocephalus or Dandy-Walker malformation if needed, and developmental support services including physical therapy, occupational therapy, and speech therapy. Regular monitoring by a multidisciplinary team including cardiologists, neurologists, and developmental specialists is recommended. Prognosis depends largely on the severity of cardiac and neurological involvement, with some patients surviving into adulthood while others may have a more guarded outcome due to severe cardiac malformations.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for 3C syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 3C syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for 3C syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 3C syndrome.
Community
No community posts yet. Be the first to share your experience with 3C syndrome.
Start the conversation →Latest news about 3C syndrome
No recent news articles for 3C syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about 3C syndrome
What is 3C syndrome?
3C syndrome, also known as Ritscher-Schinzel syndrome or craniocerebellocardiac syndrome, is a rare congenital disorder characterized by the combination of cranial, cerebellar, and cardiac malformations — hence the name '3C.' The condition affects multiple body systems, most prominently the brain, heart, and craniofacial structures. Key craniofacial features include macrocephaly, prominent forehead, hypertelorism (widely spaced eyes), depressed nasal bridge, and downslanting palpebral fissures. Cerebellar abnormalities typically involve Dandy-Walker malformation or other posterior fossa defect
At what age does 3C syndrome typically begin?
Typical onset of 3C syndrome is neonatal. Age of onset can vary across affected individuals.